États-Unis · Bourse & Finance · MarketWatch

Biopharmaceutical Company Bambusa Therapeutics Files for IPO

Publié par MarketWatch · États-Unis il y a 13 h

Biopharmaceutical company Bambusa Therapeutics filed for an initial public offering, and said it applied to list on the Nasdaq Global Select Market under the symbol BBTX. The…

Lire l'article complet sur MarketWatch Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketwatch.com)

Biopharmaceutical Company Bambusa Therapeutics Files for IPO

À lire aussi

Anthropic can’t reliably control its AI agents. It’s cutting off its internal evals from the live internet instead

An NYU professor says OpenAI's mass release of math papers wiped out early-career researchers' projects

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

Big Controversy Upends a Contest About Microscopic Videos

Why Record Crude Output Can’t Solve America’s Diesel Crisis

Biopharmaceutical Company Bambusa Therapeutics Files for IPO

Partager

À lire aussi

Anthropic can’t reliably control its AI agents. It’s cutting off its internal evals from the live internet instead

An NYU professor says OpenAI's mass release of math papers wiped out early-career researchers' projects

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

Big Controversy Upends a Contest About Microscopic Videos

Why Record Crude Output Can’t Solve America’s Diesel Crisis